{
    "xml": "<topic id=\"PHP81655\" outputclass=\"clinicalMedicinalProductInformation\" type=\"clinicalMedicinalProductInformation\" namespace=\"/clinical-medicinal-product-information/dyloject\" basename=\"dyloject\" title=\"Dyloject\">\n<title>Dyloject<tm tmtype=\"reg\"/>\n</title>\n<topic id=\"PHP82610\" outputclass=\"indicationsAndDose\" rev=\"1.26\" parent=\"/clinical-medicinal-product-information/dyloject\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Acute exacerbations of pain and postoperative pain</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By deep intramuscular injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>75&#8239;mg once daily for maximum 2 days, to be administered into the gluteal muscle.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Acute exacerbations of pain and postoperative pain (severe cases)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By deep intramuscular injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>75&#8239;mg twice daily for maximum 2 days, to be administered into the gluteal muscle.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Ureteric colic</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By deep intramuscular injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>75&#8239;mg, then 75&#8239;mg after 30&#8239;minutes if required.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Acute postoperative pain (in supervised settings)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By intravenous injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>75&#8239;mg every 4&#8211;6&#8239;hours if required for maximum 2 days; maximum 150&#8239;mg per day.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Prevention of postoperative pain</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By intravenous injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>25&#8211;50&#8239;mg, to be given after surgery; further doses given after 4&#8211;6 hours if necessary; maximum 150&#8239;mg in 24 hours for 2 days.</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<topic id=\"PHP82653\" outputclass=\"nationalFunding\" rev=\"1.8\" parent=\"/clinical-medicinal-product-information/dyloject\">\n<title>National funding/access decisions</title>\n<body>\n<section>\n<sectiondiv outputclass=\"smcDecisions\">\n<p outputclass=\"title\">Scottish Medicines Consortium (SMC) Decisions</p>\n<sectiondiv outputclass=\"smcDecision\">\n<sectiondiv>\n<p>The <i>Scottish Medicines Consortium</i> has advised (February 2008) that <i>Dyloject</i>\n<tm tmtype=\"reg\"/> is accepted for restricted use within NHS Scotland for the treatment or prevention of postoperative pain by intravenous injection in supervised healthcare settings.</p>\n</sectiondiv>\n</sectiondiv>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"clinicalMedicinalProductInformation\" href=\"#clinicalMedicinalProductInformation\" title=\"Clinical medicinal product information\" namespace=\"/clinical-medicinal-product-information\">Clinical medicinal product information</xref>\n</parents>\n<backlinks/>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"#clinicalMedicinalProductInformation\" href=\"#clinicalMedicinalProductInformation\" namespace=\"/clinical-medicinal-product-information\" title=\"Clinical medicinal product information\" count=\"1\" rel=\"link\">Clinical medicinal product information</xref>\n</links>\n</topic>",
    "id": "PHP81655",
    "outputclass": "clinicalMedicinalProductInformation",
    "type": "clinicalMedicinalProductInformation",
    "namespace": "/clinical-medicinal-product-information/dyloject",
    "basename": "dyloject",
    "title": "Dyloject",
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Acute exacerbations of pain and postoperative pain",
                        "html": "Acute exacerbations of pain and postoperative pain"
                    }
                ],
                "specificity": {
                    "routes": [
                        "deep intramuscular injection"
                    ],
                    "textContent": "By deep intramuscular injection",
                    "html": "By deep intramuscular injection"
                },
                "adult": [
                    {
                        "textContent": "75 mg once daily for maximum 2 days, to be administered into the gluteal muscle.",
                        "html": "<p>75&#8239;mg once daily for maximum 2 days, to be administered into the gluteal muscle.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Acute exacerbations of pain and postoperative pain (severe cases)",
                        "html": "Acute exacerbations of pain and postoperative pain (severe cases)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "deep intramuscular injection"
                    ],
                    "textContent": "By deep intramuscular injection",
                    "html": "By deep intramuscular injection"
                },
                "adult": [
                    {
                        "textContent": "75 mg twice daily for maximum 2 days, to be administered into the gluteal muscle.",
                        "html": "<p>75&#8239;mg twice daily for maximum 2 days, to be administered into the gluteal muscle.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Ureteric colic",
                        "html": "Ureteric colic"
                    }
                ],
                "specificity": {
                    "routes": [
                        "deep intramuscular injection"
                    ],
                    "textContent": "By deep intramuscular injection",
                    "html": "By deep intramuscular injection"
                },
                "adult": [
                    {
                        "textContent": "75 mg, then 75 mg after 30 minutes if required.",
                        "html": "<p>75&#8239;mg, then 75&#8239;mg after 30&#8239;minutes if required.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Acute postoperative pain (in supervised settings)",
                        "html": "Acute postoperative pain (in supervised settings)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intravenous injection"
                    ],
                    "textContent": "By intravenous injection",
                    "html": "By intravenous injection"
                },
                "adult": [
                    {
                        "textContent": "75 mg every 4&#8211;6 hours if required for maximum 2 days; maximum 150 mg per day.",
                        "html": "<p>75&#8239;mg every 4&#8211;6&#8239;hours if required for maximum 2 days; maximum 150&#8239;mg per day.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Prevention of postoperative pain",
                        "html": "Prevention of postoperative pain"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intravenous injection"
                    ],
                    "textContent": "By intravenous injection",
                    "html": "By intravenous injection"
                },
                "adult": [
                    {
                        "textContent": "25&#8211;50 mg, to be given after surgery; further doses given after 4&#8211;6 hours if necessary; maximum 150 mg in 24 hours for 2 days.",
                        "html": "<p>25&#8211;50&#8239;mg, to be given after surgery; further doses given after 4&#8211;6 hours if necessary; maximum 150&#8239;mg in 24 hours for 2 days.</p>"
                    }
                ]
            }
        ]
    },
    "nationalFunding": {
        "smcDecisions": [
            {
                "type": "smcDecisions",
                "textContent": "The Scottish Medicines Consortium has advised (February 2008) that Dyloject is accepted for restricted use within NHS Scotland for the treatment or prevention of postoperative pain by intravenous injection in supervised healthcare settings.",
                "html": "<p>The <i>Scottish Medicines Consortium</i> has advised (February 2008) that <i>Dyloject</i> <tm tmtype=\"reg\"/> is accepted for restricted use within NHS Scotland for the treatment or prevention of postoperative pain by intravenous injection in supervised healthcare settings.</p>"
            }
        ]
    },
    "backlinks": {},
    "links": {
        "#clinicalMedicinalProductInformation": [
            {
                "id": "clinicalMedicinalProductInformation",
                "label": "Clinical medicinal product information",
                "type": "#clinicalMedicinalProductInformation"
            }
        ]
    }
}